Thomas E Whittaker
Overview
Explore the profile of Thomas E Whittaker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Powell A, Whittaker T, Whittow W, Sambles J, Hibbins A
ACS Photonics
. 2024 Mar;
11(3):1156-1162.
PMID: 38523749
Geometries that replicate the behavior of metal nanostructures at much lower frequencies via texturing surfaces so they will support a surface wave have been a central pillar of metamaterials research....
2.
Bahal S, Zinicola M, Moula S, Whittaker T, Schejtman A, Naseem A, et al.
J Allergy Clin Immunol
. 2024 Mar;
154(1):195-208.e8.
PMID: 38479630
Background: X-linked agammaglobulinemia (XLA) is an inborn error of immunity that renders boys susceptible to life-threatening infections due to loss of mature B cells and circulating immunoglobulins. It is caused...
3.
Dorado E, Doria M, Nagelkerke A, McKenzie J, Maneta-Stavrakaki S, Whittaker T, et al.
J Extracell Vesicles
. 2024 Mar;
13(3):e12419.
PMID: 38443328
Extracellular vesicles (EVs), including exosomes and microvesicles, mediate intercellular communication in cancer, from development to metastasis. EV-based liquid biopsy is a promising strategy for cancer diagnosis as EVs can be...
4.
Whittaker T, Moula S, Bahal S, Bakri F, Hayajneh W, Daoud A, et al.
Hum Gene Ther
. 2023 Dec;
35(7-8):298-312.
PMID: 38062734
Replacing a faulty gene with a correct copy has become a viable therapeutic option as a result of recent progress in gene editing protocols. Targeted integration of therapeutic genes in...
5.
Whittaker T, Santilli G
Mol Ther
. 2023 Nov;
31(12):3367-3368.
PMID: 37980903
No abstract available.
6.
Morfopoulou S, Buddle S, Torres Montaguth O, Atkinson L, Guerra-Assuncao J, Moradi Marjaneh M, et al.
Nature
. 2023 Mar;
617(7961):564-573.
PMID: 36996872
Since its first identification in Scotland, over 1,000 cases of unexplained paediatric hepatitis in children have been reported worldwide, including 278 cases in the UK. Here we report an investigation...
7.
Minelli C, Wywijas M, Bartczak D, Cuello-Nunez S, Infante H, Deumer J, et al.
Nanoscale
. 2022 Mar;
14(12):4690-4704.
PMID: 35262538
We describe the outcome of a large international interlaboratory study of the measurement of particle number concentration of colloidal nanoparticles, project 10 of the technical working area 34, "Nanoparticle Populations"...
8.
Nagelkerke A, Ojansivu M, van der Koog L, Whittaker T, Cunnane E, Silva A, et al.
Adv Drug Deliv Rev
. 2021 Apr;
175:113775.
PMID: 33872693
Extracellular vesicles (EVs) are biological nanoparticles naturally secreted by cells, acting as delivery vehicles for molecular messages. During the last decade, EVs have been assigned multiple functions that have established...
9.
Maynard S, Gelmi A, Skaalure S, Pence I, Lee-Reeves C, Sero J, et al.
ACS Nano
. 2020 Nov;
14(12):17321-17332.
PMID: 33215498
A common approach to tailoring synthetic hydrogels for regenerative medicine applications involves incorporating RGD cell adhesion peptides, yet assessing the cellular response to engineered microenvironments at the nanoscale remains challenging....
10.
Zwi-Dantsis L, Winter C, Kauscher U, Ferrini A, Wang B, Whittaker T, et al.
Nanoscale
. 2020 Sep;
12(38):19844-19854.
PMID: 32969445
Extracellular vesicles (EVs) represent a promising cell-free alternative for treatment of cardiovascular diseases. Nevertheless, the lack of standardised and reproducible isolation methods capable of recovering pure, intact EVs presents a...